APA Цитирование

Alkabbani, W., & Gamble, J. (2021). Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date. Drug Des Devel Ther.

Chicago-стиль цитирования

Alkabbani, Wajd, and John-Michael Gamble. "Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date." Drug Des Devel Ther 2021.

MLA-цитирование

Alkabbani, Wajd, and John-Michael Gamble. "Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date." Drug Des Devel Ther 2021.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.